rs225014

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_013989.5(DIO2):​c.274A>G​(p.Thr92Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 1,605,544 control chromosomes in the GnomAD database, including 117,581 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as other (no stars).

Frequency

Genomes: 𝑓 0.40 ( 12048 hom., cov: 27)
Exomes 𝑓: 0.38 ( 105533 hom. )

Consequence

DIO2
NM_013989.5 missense

Scores

17

Clinical Significance

other no assertion criteria provided O:1

Conservation

PhyloP100: -0.411

Publications

241 publications found
Variant links:
Genes affected
DIO2 (HGNC:2884): (iodothyronine deiodinase 2) The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the conversion of prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4) to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by outer ring 5'-deiodination. This gene is widely expressed, including in thyroid and brain. It is thought to be responsible for the 'local' production of T3, and thus important in influencing thyroid hormone action in these tissues. It has also been reported to be highly expressed in thyroids of patients with Graves disease, and in follicular adenomas. The intrathyroidal T4 to T3 conversion by this enzyme may contribute significantly to the relative increase in thyroidal T3 production in these patients. This protein is a selenoprotein containing the non-standard amino acid, selenocysteine (Sec), which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Unlike the other two members (DIO1 and DIO3) of this enzyme family, the mRNA for this gene contains an additional in-frame UGA codon that has been reported (in human) to function either as a Sec or a stop codon, which can result in two isoforms with one or two Sec residues; however, only the upstream Sec (conserved with the single Sec residue found at the active site in DIO1 and DIO3) was shown to be essential for enzyme activity (PMID:10403186). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2018]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.324709E-5).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIO2NM_013989.5 linkc.274A>G p.Thr92Ala missense_variant Exon 2 of 2 ENST00000438257.9 NP_054644.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIO2ENST00000438257.9 linkc.274A>G p.Thr92Ala missense_variant Exon 2 of 2 1 NM_013989.5 ENSP00000405854.5

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
59308
AN:
149900
Hom.:
12021
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.446
Gnomad AMI
AF:
0.319
Gnomad AMR
AF:
0.477
Gnomad ASJ
AF:
0.433
Gnomad EAS
AF:
0.434
Gnomad SAS
AF:
0.493
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.358
Gnomad OTH
AF:
0.396
GnomAD2 exomes
AF:
0.410
AC:
97626
AN:
238102
AF XY:
0.407
show subpopulations
Gnomad AFR exome
AF:
0.446
Gnomad AMR exome
AF:
0.567
Gnomad ASJ exome
AF:
0.431
Gnomad EAS exome
AF:
0.437
Gnomad FIN exome
AF:
0.266
Gnomad NFE exome
AF:
0.358
Gnomad OTH exome
AF:
0.392
GnomAD4 exome
AF:
0.377
AC:
548354
AN:
1455534
Hom.:
105533
Cov.:
42
AF XY:
0.379
AC XY:
273799
AN XY:
723358
show subpopulations
African (AFR)
AF:
0.446
AC:
14895
AN:
33414
American (AMR)
AF:
0.553
AC:
24246
AN:
43860
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
11247
AN:
25960
East Asian (EAS)
AF:
0.408
AC:
16119
AN:
39536
South Asian (SAS)
AF:
0.480
AC:
40927
AN:
85220
European-Finnish (FIN)
AF:
0.271
AC:
14355
AN:
53060
Middle Eastern (MID)
AF:
0.353
AC:
2030
AN:
5758
European-Non Finnish (NFE)
AF:
0.362
AC:
401293
AN:
1108542
Other (OTH)
AF:
0.386
AC:
23242
AN:
60184
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
18715
37430
56145
74860
93575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13094
26188
39282
52376
65470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.396
AC:
59382
AN:
150010
Hom.:
12048
Cov.:
27
AF XY:
0.396
AC XY:
28964
AN XY:
73134
show subpopulations
African (AFR)
AF:
0.446
AC:
18101
AN:
40542
American (AMR)
AF:
0.477
AC:
7217
AN:
15116
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
1498
AN:
3456
East Asian (EAS)
AF:
0.433
AC:
2183
AN:
5040
South Asian (SAS)
AF:
0.492
AC:
2330
AN:
4732
European-Finnish (FIN)
AF:
0.258
AC:
2610
AN:
10134
Middle Eastern (MID)
AF:
0.299
AC:
86
AN:
288
European-Non Finnish (NFE)
AF:
0.358
AC:
24234
AN:
67706
Other (OTH)
AF:
0.399
AC:
835
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1733
3466
5198
6931
8664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.380
Hom.:
39503
Bravo
AF:
0.413
TwinsUK
AF:
0.365
AC:
1352
ALSPAC
AF:
0.368
AC:
1420
ESP6500AA
AF:
0.431
AC:
1725
ESP6500EA
AF:
0.367
AC:
3076
ExAC
AF:
0.402
AC:
48511
Asia WGS
AF:
0.469
AC:
1627
AN:
3478

ClinVar

Significance: other
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Levothyroxine response Other:1
-
Pharmacogenomics/Precision medicine lab, University of Petra
Significance:other
Review Status:no assertion criteria provided
Collection Method:research

- This SNP was not associated with any of thyroid panel hormones in the study

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.088
DANN
Benign
0.57
DEOGEN2
Benign
0.025
T;T;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.11
.;T;.
MetaRNN
Benign
0.000023
T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.69
N;N;.
PhyloP100
-0.41
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.11
N;N;N
REVEL
Benign
0.0050
Sift
Benign
0.78
T;T;T
Sift4G
Benign
0.77
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.034
MPC
0.24
ClinPred
0.0068
T
GERP RS
-1.4
Varity_R
0.033
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs225014; hg19: chr14-80669580; COSMIC: COSV70445216; API